Polatuzumab Vedotin/Rituximab Regimen

Preferred Label : Polatuzumab Vedotin/Rituximab Regimen;

NCIt synonyms : Polatuzumab Vedotin/Rituximab; Rituximab/Polatuzumab Vedotin Regimen; Polatuzumab Vedotin-Rituximab; Polatuzumab Vedotin-Rituximab Regimen; Polivy/Rituxan Regimen; Polatuzumab Vedotin Plus Rituximab; Polatuzumab Vedotin-piiq/Rituximab Regimen; Polatuzumab Vedotin-piiq Plus Rituximab;

NCIt definition : A regimen consisting of polatuzumab vedotin and rituximab that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL).;

NCI Metathesaurus CUI : CL1794039;

Détails

Origin ID

C188902;

UMLS CUI

C5708110;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Polatuzumab Vedotin [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients